PDA Trains Kazakhstan Pharmaceutical Regulators

The Parenteral Drug Association (PDA, Bethesda, MD,  www.pda.org) finishedthe second stage of GMP training for representatives from the Republicof Kazakhstan's Ministry of Health. Over the next three years, PDAplans to train 100 delegates from Kazakhstan in an effort "to develop astronger, more informed pharmaceutical regulatory agency," PDA said inan official press release.

The training focuses on US and European regulations and requirementsnecessary for the review and approval of drugs and biologic products.Sessions also cover a range of drug development topics includingclinical trials, manufacturing, labeling, and advertising.